Radiographic and pathologic response of myxoid liposarcoma treated with preoperative radiotherapy
, , , , , , oraz
16 cze 2025
O artykule
Kategoria artykułu: research article
Data publikacji: 16 cze 2025
Zakres stron: 176 - 182
Otrzymano: 14 sty 2025
Przyjęty: 21 kwi 2025
DOI: https://doi.org/10.2478/raon-2025-0032
Słowa kluczowe
© 2025 Robert W Gao et al., published by Sciendo
This work is licensed under the Creative Commons Attribution 4.0 International License.
FIGURE 1.

FIGURE 2.

FIGURE 3.

Dosimetric comparison of original plan and replan for an individual patient
Original plan | Replan | |
---|---|---|
V30Gy(%) | 10.3% | 0.3% |
V45Gy(%) | 5.4% | 1.5% |
V50Gy(%) | 1.8% | 0.4% |
V30Gy(cc) | 101 cc | 82 cc |
V45Gy(cc) | 13 cc | 6 cc |
V50Gy(cc) | 2 cc | 1 cc |
Mean dose | 23 Gy | 16 Gy |
Mean dose | 10 Gy | 6 Gy |
Radiographic and pathologic characteristics
N = 20 | |
---|---|
Stable | 4 (20%) |
Decrease | 16 (80%) |
Increase | 1 (5%) |
Not present | 15 (75%) |
Decrease | 4 (20%) |
Increase | 4 (20%) |
Stable | 5 (25%) |
Decrease | 11 (55%) |
Increase | 11 (55%) |
Stable | 9 (45%) |
Low | 18 (90%) |
High | 2 (10%) |
Negative | 18 (90%) |
Positive | 2 (10%) |
Median (IQR) | 9 (7–15) |
Median (IQR) | 5 (5–35) |
Median (IQR) | 16 (80%) |
Patient and radiotherapy characteristics
N = 20 | |
---|---|
Female | 8 (40%) |
Male | 12 (60%) |
Median (IQR) | 51 (39–60) |
Lower extremity, proximal | 13 (65%) |
Lower extremity, distal | 3 (15%) |
Trunk | 4 (20%) |
1 (5%) | |
Neoadjuvant | 1 (5%) |
Adjuvant | 1 (5%) |
3D conformal | 11 (55%) |
IMRT | 8 (40%) |
IMPT | 1 (5%) |
36 Gy | 3 (15%) |
50 Gy | 16 (80%) |
56.25 Gy | 1 (5%) |
1 (5%) | |
1 (5%) |